AIA Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
AIA Group's ELV Position: Q2 2026 in Review
AIA Group increased its Elevance Health (ELV) stake by 34% in Q2 2026, buying an estimated $6.24M and bringing the position to 66,004 shares worth $25.5M. The position accounts for 0.32% of the portfolio, ranked #47.
AIA Group first reported a position in ELV in Q1 2021 and has held it in 21 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- AIA Group held 66,004 shares of Elevance Health worth $25.5M as of Q2 2026.
- AIA Group bought 16,818 Elevance Health shares in Q2 2026, an estimated $6.24M.
- Elevance Health made up 0.32% of AIA Group's portfolio in Q2 2026, its #47 holding.
- AIA Group first reported a position in Elevance Health in Q1 2021 and has held it in 21 quarters since.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.